ARTICLE | Clinical News
NVTL0001: Began Phase I trial
May 29, 2001 7:00 AM UTC
Novactyl Inc., St. Louis, Mo. Product: NVTL0001 Business: Infectious diseases Therapeutic category: Viral replication Target: Viral proteins Description: Topical cream containing a small molecule that...